Home›Search›Transplantation and Cellular Therapy

Transplantation and Cellular Therapy

Elsevier B.V. · Netherlands · Est. 2020

ISSN2666-6367

SJR Q1✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

2.251

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

1.224

Total Worksi

6,368

Total Citationsi

18,944

2yr Mean Citednessi

0.79

Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Transplantation and Cellular Therapy is dedicated to the comprehensive development and advancement of the interdisciplinary field of hematopoietic cell transplantation (HCT) and cellular therapies. The journal focuses on current technology and knowledge in hematopoetic stem cell transplantation and transplant and non-transplant cellular immunotherapies.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionNetherlands

Primary LanguageEnglish

1st Year Published2020

Annual Volume~ 1,062 articles / year

StatusActive (last: 2026)

Total Publications6,368

Publisher OrgElsevier BV

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Elsevier B.V.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2666-6367

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

107

1.7k

2020

974

6.3k

2021

5.5k

2022

965

3.7k

2023

992

2.3k

2024

1.2k

957

2025

1.2k

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cell BiologyQ1

HematologyQ1

Immunology and AllergyQ1

Molecular MedicineQ1

TransplantationQ1

Subject Classification

Web of Science Categories

HematologyImmunologyTransplantation

Scopus Categories

HematologyTransplantationImmunology and AllergyMolecular MedicineCell Biology

Research Topics (OpenAlex)

Hematopoietic Stem Cell TransplantationCAR-T cell therapy researchAcute Lymphoblastic Leukemia researchAcute Myeloid Leukemia ResearchRenal Transplantation Outcomes and TreatmentsChronic Myeloid Leukemia TreatmentsMultiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentImmune Cell Function and Interaction

Frequently asked questions about Transplantation and Cellular Therapy

Is Transplantation and Cellular Therapy a predatory journal?

PubScope has no integrity flags on record for Transplantation and Cellular Therapy: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Transplantation and Cellular Therapy?

Transplantation and Cellular Therapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 0.79.

Is Transplantation and Cellular Therapy indexed in Scopus and Web of Science?

Transplantation and Cellular Therapy is indexed in Web of Science, Scopus.